why choose us

Clinical Trials Search

Showing 10,410 of 132,963 result(s)
Phase 2 Futibatinib in Combination With PD-1 Antibody Based Standard of Care in Solid Tumors

Status: Completed

Condition: Locally Advanced Unresectable or Metastatic Esophageal Cancer

Interventions: TAS-120 20 mg tablets, oral; once daily

Date: 2023-07-06

The Osteoarthritis Prevention Study

Status: NOT_YET_RECRUITING

Condition: Osteoarthritis, Knee

Interventions: Group and individual weight loss and weight maintenance sessions combined with exercise throughout the 48 months.

Date: 2023-07-06

A Retrospective Analysis of Outcomes in Patients With Hepatorenal Syndrome at Methodist Dallas Medical Center

Status: Completed

Condition: Hepatorenal Syndrome

Interventions: 1.2.1.
To perform a retrospective analysis of patients with HRS with the aim of comparing various treatment modalities such as vasoconstrictors,

Date: 2023-07-06

A Study of Spoken Language in Mania

Status: Completed

Condition: Manic Episode

Interventions: Research interview to capture speech data with high quality cardioid headset microphone

Date: 2023-07-06

Pharyngeal Muscle Control Mechanisms of Atomoxetine-plus-oxybutynin in Obstructive Sleep Apnea

Status: NOT_YET_RECRUITING

Condition: OSA

Interventions: 80mg Atomoxetine and 5mg Oxybutynin administered 30mins prior to bed

Date: 2023-07-06

Clinical Outcome of Pericardial Closure Using Gentrix Following Cardiac Surgery

Status: Completed

Condition: Clinical Outcome of Pericardial Closure Using Gentrix

Interventions: To determine feasibility and effectiveness of Gentrix for cardiac use, and if this product is patient population specific.

Date: 2023-07-06

Efficacy of Liposomal Bupivacaine Post Septorhinoplasty

Status: NOT_YET_RECRUITING

Condition: Rhinoplasty

Interventions: Patients will receive post-operative liposomal bupivacaine (EXPAREL®) at the surgical site at the completion of their septorhinoplasty.

Date: 2023-07-06

Injury Prevention Model For K-1 Students

Status: Completed

Condition: Trauma Injury

Interventions: Classroom Education session appropriate for elementary school children

Date: 2023-07-06

Oxymetazoline Drops for Acquired Blepharoptosis From Synkinesis

Status: NOT_YET_RECRUITING

Condition: Blepharoptosis

Interventions:

Oxymetazoline was initially developed in 1961.
It is a direct sympathomimetic, binding directly to alpha-1 and alpha-2 receptors.
Current

Date: 2023-07-06

Clopidogrel Hyper-Responsiveness: Incidence and Associated Outcomes in Patients With Cerebral Aneurysms

Status: Completed

Condition: Cerebral Aneurysm

Interventions:

Date: 2023-07-06